\-\ Texto\\:\\ \ \(0\)\
\-\ liver\\ edge\\ palpable\\ to\\ 4\\ cm\\ below\\ ribcage\\ on\\ exam\\.\ \(0\)\
\-\ although\\ the\\ patient\\ had\\ used\\ tamoxifen\\ in\\ the\\ past\\,\\ she\\ was\\ considered\\ to\\ be\\ chemotherapy\\ naive\\.\\ due\\ to\\ systemic\\ dissemination\\ of\\ disease\\ it\\ was\\ decided\\ to\\ attempt\\ chemotherapy\\ first\\ and\\ reserve\\ radiation\\ therapy\\ as\\ a\\ palliative\\ option\\.\ \(0\)\
\-\ multiple\\ liver\\ lesions\\ replacing\\ approximately\\ 80\\%\\ of\\ liver\\ volume\\.\\ multiple\\ lesions\\ of\\ brain\\ parenchyma\\ in\\ bilateral\\ parietooccipital\\ regions\\ with\\ diffuse\\ enhancement\\ of\\ overlying\\ skull\\ and\\ dura\\.\ \(0\)\
\-\ metastatic\\ ductal\\ carcinoma\\ \\(breast\\)\ \(0\)\
\-\ metastatic\\ disease\\ \\-\\ melanoma\ \(0\)\
\-\ metastatic\\ disease\\ \\-\\ ductal\\ breast\\ ca\ \(0\)\
\-\ 60\\ year\\ old\\ woman\\ with\\ pmh\\ of\\ t1bn0m0\\ breast\\ ca\\ and\\ melanoma\\,\\ both\\ 9\\ years\\ ago\\.\\ s\\/p\\ lumpectomy\\,\\ xrt\\,\\ tamoxifen\\,\\ local\\ excision\\.\\ presents\\ with\\ 3\\ months\\ of\\ early\\ satiety\\ and\\ nausea\\.\\ additional\\ complaint\\ of\\ blurred\\ vision\\ when\\ looking\\ to\\ her\\ left\\ while\\ driving\\ for\\ 1\\ week\\.\ \(0\)\
\-\ this\\ is\\ a\\ rather\\ unfortunate\\ case\\ of\\ a\\ woman\\ who\\ was\\ concurrently\\ diagnosed\\ with\\ stage\\ i\\ breast\\ cancer\\ and\\ melanoma\\ 8\\ years\\ ago\\.\\ neither\\ disease\\ demonstrated\\ pathologic\\ lymph\\ node\\ involvement\\ at\\ time\\ of\\ initial\\ diagnosis\\ \\/\\ treatment\\.\\ sadly\\ she\\ now\\ demonstrates\\ diffuse\\ metastasis\\ of\\ pathologically\\ proven\\ ductal\\ carcinoma\\ involving\\ approximately\\ 80\\%\\ of\\ her\\ liver\\,\\ her\\ parietooccipital\\ brain\\ parenchyma\\ and\\ overlying\\ skull\\ and\\ meninges\\,\\ as\\ well\\ as\\ the\\ body\\ of\\ her\\ l4\\ vertebrae\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ parietooccipital\\:\\ 0\\.24413107889116836\ \(0\)\
\-\ breast\\:\\ 0\\.22170953668918278\ \(0\)\
\-\ melanoma\\:\\ 0\\.21383791041510275\ \(0\)\
\-\ liver\\:\\ 0\\.21061910678952409\ \(0\)\
\-\ ductal\\:\\ 0\\.20150811284883005\ \(0\)\
\-\ tamoxifen\\:\\ 0\\.20106032330088866\ \(0\)\
\-\ her\\:\\ 0\\.19074232247328368\ \(0\)\
\-\ of\\:\\ 0\\.1792452830323853\ \(0\)\
\-\ ca\\:\\ 0\\.13024507341348038\ \(0\)\
\-\ overlying\\:\\ 0\\.1300559463711572\ \(0\)\
\-\ disease\\:\\ 0\\.12815960460467907\ \(0\)\
\-\ metastatic\\:\\ 0\\.12558673305453025\ \(0\)\
\-\ parenchyma\\:\\ 0\\.1240090421721598\ \(0\)\
\-\ skull\\:\\ 0\\.12385911816600406\ \(0\)\
\-\ ribcage\\:\\ 0\\.12206553944558418\ \(0\)\
\-\ naive\\:\\ 0\\.12206553944558418\ \(0\)\
\-\ t1bn0m0\\:\\ 0\\.12206553944558418\ \(0\)\
\-\ 80\\:\\ 0\\.11907980037373052\ \(0\)\
\-\ sadly\\:\\ 0\\.11664013954764679\ \(0\)\
\-\ ago\\:\\ 0\\.11169550864223834\ \(0\)\
\-\ and\\:\\ 0\\.11040613477113555\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.10839625965423352\ \(0\)\
\-\ reserve\\:\\ 0\\.10736535716202578\ \(0\)\
\-\ concurrently\\:\\ 0\\.10530271584991889\ \(0\)\
\-\ unfortunate\\:\\ 0\\.10351597467434216\ \(0\)\
\-\ dissemination\\:\\ 0\\.0992548463904076\ \(0\)\
\-\ approximately\\:\\ 0\\.09740600480017664\ \(0\)\
\-\ diffuse\\:\\ 0\\.09573456072123215\ \(0\)\
\-\ to\\:\\ 0\\.0954096026947517\ \(0\)\
\-\ brain\\:\\ 0\\.09516569869107101\ \(0\)\
\-\ satiety\\:\\ 0\\.09510476175250693\ \(0\)\
\-\ driving\\:\\ 0\\.09424119228872115\ \(0\)\
\-\ years\\:\\ 0\\.09357643087651486\ \(0\)\
\-\ replacing\\:\\ 0\\.09342999346929613\ \(0\)\
\-\ meninges\\:\\ 0\\.09266517487846736\ \(0\)\
\-\ as\\:\\ 0\\.09199133925572613\ \(0\)\
\-\ carcinoma\\:\\ 0\\.09131225656735054\ \(0\)\
\-\ she\\:\\ 0\\.09087281541082935\ \(0\)\
\-\ blurred\\:\\ 0\\.08938526908090229\ \(0\)\
\-\ neither\\:\\ 0\\.08881579239078374\ \(0\)\
\-\ pathologically\\:\\ 0\\.08881579239078374\ \(0\)\
\-\ lumpectomy\\:\\ 0\\.08826956624092547\ \(0\)\
\-\ xrt\\:\\ 0\\.08774476632871679\ \(0\)\
\-\ lesions\\:\\ 0\\.0876723962612746\ \(0\)\
\-\ decided\\:\\ 0\\.08723977498052997\ \(0\)\
\-\ looking\\:\\ 0\\.0853912291567204\ \(0\)\
\-\ dura\\:\\ 0\\.08302377551695571\ \(0\)\
\-\ palliative\\:\\ 0\\.08231936643077939\ \(0\)\
\-\ was\\:\\ 0\\.07980348576449851\ \(0\)\
\-\ woman\\:\\ 0\\.07950403753929983\ \(0\)\
\-\ vertebrae\\:\\ 0\\.07899478385530445\ \(0\)\
\-\ attempt\\:\\ 0\\.07872981118573771\ \(0\)\
\-\ edge\\:\\ 0\\.07700882288229334\ \(0\)\
\-\ option\\:\\ 0\\.07700882288229334\ \(0\)\
\-\ proven\\:\\ 0\\.07700882288229334\ \(0\)\
\-\ multiple\\:\\ 0\\.07466764775733756\ \(0\)\
\-\ l4\\:\\ 0\\.07287412718519536\ \(0\)\
\-\ pmh\\:\\ 0\\.06906715577122059\ \(0\)\
\-\ systemic\\:\\ 0\\.06773404049667232\ \(0\)\
\-\ rather\\:\\ 0\\.06761918414722098\ \(0\)\
\-\ volume\\:\\ 0\\.06705924125341106\ \(0\)\
\-\ complaint\\:\\ 0\\.06610685406592398\ \(0\)\
\-\ vision\\:\\ 0\\.06610685406592398\ \(0\)\
\-\ local\\:\\ 0\\.0657043971853901\ \(0\)\
\-\ node\\:\\ 0\\.0656056463124331\ \(0\)\
\-\ regions\\:\\ 0\\.06550761889559008\ \(0\)\
\-\ below\\:\\ 0\\.0628580713187326\ \(0\)\
\-\ pathologic\\:\\ 0\\.06254135398700694\ \(0\)\
\-\ stage\\:\\ 0\\.060783988635639524\ \(0\)\
\-\ excision\\:\\ 0\\.06018024641449569\ \(0\)\
\-\ with\\:\\ 0\\.05978412734876178\ \(0\)\
\-\ considered\\:\\ 0\\.05947751926943819\ \(0\)\
\-\ lymph\\:\\ 0\\.05935362317543408\ \(0\)\
\-\ additional\\:\\ 0\\.05916990382402571\ \(0\)\
\-\ nausea\\:\\ 0\\.05863341262007014\ \(0\)\
\-\ used\\:\\ 0\\.0571420627462371\ \(0\)\
\-\ 60\\:\\ 0\\.05708989627644665\ \(0\)\
\-\ metastasis\\:\\ 0\\.05594299089791597\ \(0\)\
\-\ diagnosed\\:\\ 0\\.055290145199453127\ \(0\)\
\-\ involvement\\:\\ 0\\.05524470990094824\ \(0\)\
\-\ early\\:\\ 0\\.05501981918612502\ \(0\)\
\-\ palpable\\:\\ 0\\.05362341094983889\ \(0\)\
\-\ involving\\:\\ 0\\.05346363970767851\ \(0\)\
\-\ now\\:\\ 0\\.05239566824728059\ \(0\)\
\-\ although\\:\\ 0\\.05196283215104696\ \(0\)\
\-\ first\\:\\ 0\\.05150920625001852\ \(0\)\
\-\ week\\:\\ 0\\.05133874939005549\ \(0\)\
\-\ initial\\:\\ 0\\.05120393028927903\ \(0\)\
\-\ cancer\\:\\ 0\\.050840032687963964\ \(0\)\
\-\ radiation\\:\\ 0\\.05058146072770515\ \(0\)\
\-\ body\\:\\ 0\\.0502338909899818\ \(0\)\
\-\ past\\:\\ 0\\.04968392251523462\ \(0\)\
\-\ while\\:\\ 0\\.0493294466186209\ \(0\)\
\-\ demonstrated\\:\\ 0\\.046909308414506856\ \(0\)\
\-\ when\\:\\ 0\\.04610669888555742\ \(0\)\
\-\ the\\:\\ 0\\.04569077389687655\ \(0\)\
\-\ time\\:\\ 0\\.0452416974904146\ \(0\)\
\-\ months\\:\\ 0\\.04442923532938896\ \(0\)\
\-\ enhancement\\:\\ 0\\.043933230336511725\ \(0\)\
\-\ due\\:\\ 0\\.04387492661658299\ \(0\)\
\-\ therapy\\:\\ 0\\.043855548361852015\ \(0\)\
\-\ cm\\:\\ 0\\.0438361981306373\ \(0\)\
\-\ who\\:\\ 0\\.04317598826987903\ \(0\)\
\-\ both\\:\\ 0\\.04256439901371714\ \(0\)\
\-\ bilateral\\:\\ 0\\.04102163527212474\ \(0\)\
\-\ diagnosis\\:\\ 0\\.03956804033114677\ \(0\)\
\-\ it\\:\\ 0\\.039071380666014344\ \(0\)\
\-\ exam\\:\\ 0\\.038423695277123006\ \(0\)\
\-\ case\\:\\ 0\\.03834649881750671\ \(0\)\
\-\ demonstrates\\:\\ 0\\.03834649881750671\ \(0\)\
\-\ had\\:\\ 0\\.03802955641690048\ \(0\)\
\-\ in\\:\\ 0\\.03797599873115528\ \(0\)\
\-\ well\\:\\ 0\\.036958530354833534\ \(0\)\
\-\ presents\\:\\ 0\\.03671784349401794\ \(0\)\
\-\ treatment\\:\\ 0\\.036359210768849126\ \(0\)\
\-\ be\\:\\ 0\\.0309633325211728\ \(0\)\
\-\ at\\:\\ 0\\.028830158357729258\ \(0\)\
\-\ this\\:\\ 0\\.026227772214637745\ \(0\)\
\-\ left\\:\\ 0\\.026037241670269638\ \(0\)\
\-\ patient\\:\\ 0\\.024825758329944075\ \(0\)\
\-\ year\\:\\ 0\\.02352287370074547\ \(0\)\
\-\ for\\:\\ 0\\.02313451644347914\ \(0\)\
\-\ on\\:\\ 0\\.023052451282510707\ \(0\)\
\-\ old\\:\\ 0\\.022590101397519723\ \(0\)\
\-\ is\\:\\ 0\\.02090301856842967\ \(0\)\
